Pancreatic Cancer Research

ResearcherUniversity of Illinois ChicagoActive in the last 2 years

Pietro Addeo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0046-7973; OpenAlex author ID A5028951506. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
97
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 2 papers

Papers 16

  1. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  2. Futility in adenosquamous pancreatic cancer. Co-author DOI 10.1186/s12957-026-04351-1↗
  3. Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Adenocarcinoma. First author DOI 10.1097/sla.0000000000006779↗
  4. Distal Pancreatectomy with Celiac Axis and Venous Resection with Hepatic Artery and Venous Reconstruction (DP-CARV) for Locally Advanced Pancreatic Adenocarcin… Co-author DOI 10.1245/s10434-024-16623-9↗
  5. Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter T… Co-author DOI 10.1245/s10434-024-16735-2↗
  6. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Co-author DOI 10.1007/s13304-024-01860-0↗
  7. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
  8. Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report. Co-author DOI 10.12998/wjcc.v11.i6.1372↗
  9. Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?" Co-author DOI 10.1097/sla.0000000000004408↗
  10. Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience Wit… First author DOI 10.1097/sla.0000000000003010↗
  11. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Co-author DOI 10.1093/jnci/djz073↗
  12. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Co-author DOI 10.1016/j.surg.2017.03.008↗
  13. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal… Co-author DOI 10.1016/j.surg.2013.09.003↗
  14. A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. Co-author DOI 10.1016/j.jamcollsurg.2013.08.007↗
  15. Robotic palliation for unresectable pancreatic cancer and distal cholangiocarcinoma. First author DOI 10.1002/rcs.370↗
  16. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer… Co-author DOI 10.1111/j.1440-1746.2010.06525.x↗

Closest collaborators

The 25 strongest of 97 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Philippe Bachellier · 10 shared papers, 2013–2026 · strength 1.56
  2. Gerlinde Avérous · 3 shared papers, 2017–2025 · strength 0.56
  3. Gennaro Nappo · 3 shared papers, 2017–2026 · strength 0.40
  4. Julie Navez · 2 shared papers, 2025–2026 · strength 0.34
  5. Benabdelghani Meher · 1 shared paper, 2023 · strength 0.24
  6. Fabien Moinard‐Butot · 1 shared paper, 2023 · strength 0.24
  7. Cristina Vallejo Bernad · 1 shared paper, 2026 · strength 0.18
  8. Bodil Andersson · 1 shared paper, 2026 · strength 0.18
  9. Bergþór Björnsson · 1 shared paper, 2026 · strength 0.18
  10. Santiago Sánchez-Cabús · 1 shared paper, 2026 · strength 0.18
  11. Sebastian Manuel Staubli · 1 shared paper, 2026 · strength 0.18
  12. Dimitrios E. Giakoustidis · 1 shared paper, 2026 · strength 0.18
  13. Maria João Amaral · 1 shared paper, 2026 · strength 0.18
  14. Anita Balakrishnan · 1 shared paper, 2026 · strength 0.18
  15. Alessandro Zerbi · 1 shared paper, 2026 · strength 0.18
  16. Dimitrios Lytras · 1 shared paper, 2026 · strength 0.18
  17. José Manuel Ramia · 1 shared paper, 2026 · strength 0.18
  18. Sanjay Pandanaboyana · 1 shared paper, 2026 · strength 0.18
  19. Gerardo Blanco‐Fernández · 1 shared paper, 2026 · strength 0.18
  20. Mario Serradilla-Martín · 1 shared paper, 2026 · strength 0.18
  21. Jakob Kirkegård · 1 shared paper, 2026 · strength 0.18
  22. Juli Busquets · 1 shared paper, 2026 · strength 0.18
  23. Ahmad Mahamid · 1 shared paper, 2026 · strength 0.18
  24. Elizabeth Pando · 1 shared paper, 2026 · strength 0.18
  25. Fernando Burdı́o · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.